**Core Concept**
Amyloidosis refers to a group of diseases characterized by the accumulation of insoluble fibrils composed of various proteins in different tissues, leading to organ dysfunction. This condition can be primary (idiopathic), secondary (associated with chronic diseases like multiple myeloma), or hereditary.

**Why the Correct Answer is Right**
Amyloidosis of the spleen is not typically associated with severe anemia. Instead, splenic amyloidosis often leads to hypersplenism, a condition characterized by the spleen's excessive removal of blood cells from the circulation. This results in cytopenias, including anemia, thrombocytopenia, and leukopenia. However, the severity of anemia is variable and not always severe. The spleen's accumulation of amyloid fibrils can lead to splenomegaly, which can be a significant clinical finding.

**Why Each Wrong Option is Incorrect**
**Option A:** Amyloidosis associated with multiple myeloma actually has a relatively good prognosis, as treatment of the underlying myeloma can lead to resolution of the amyloidosis. In contrast, primary amyloidosis (AL amyloidosis) has a poorer prognosis.
**Option B:** Fine-needle biopsy of subcutaneous abdominal fat is a simple and reliable method for diagnosing secondary systemic amyloidosis. This procedure involves taking a small sample of fat tissue, which can be stained to detect amyloid deposits.
**Option C:** Hepatic amyloid disease indeed produces hepatomegaly, which can be a significant finding. Additionally, patients may experience symptoms related to liver dysfunction, including jaundice.

**Clinical Pearl / High-Yield Fact**
When diagnosing amyloidosis, it's essential to consider the underlying cause, as the prognosis and treatment options differ significantly. Primary amyloidosis (AL amyloidosis) has a poorer prognosis compared to secondary amyloidosis associated with chronic diseases.

**✓ Correct Answer: D. Amyloidosis of the spleen is associated with severe anemia**